Systematic investigation of non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs)

被引：6
|
作者：
Beyer, A
Lawtrakul, L
Hannongbua, S
Wolschann, P
机构：
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Thammasat Univ, SIIT, Dept Common & Grad Studies, Pathum Thani 12121, Thailand
[3] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok 10900, Thailand
[4] Inst Theoret Chem & Struct Biol, A-1090 Vienna, Austria
来源：
MONATSHEFTE FUR CHEMIE | 2004年 / 135卷 / 08期
关键词：
non-nucleoside reverse transcriptase inhibitors (NNRTIs); inhibition mechanism; viral mutation; drug resistance;
D O I：
10.1007/s00706-004-0173-y
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The 44 crystal structures of NNRTIs complexed with HIV-1 reverse transcriptase (RT) have been analyzed in detail especially the orientation geometries and the distances between inhibitor molecules and surrounding amino acids. In general, various NNIs bind to the same region of the HIV-1 RT in the palm subdomain of p66, but subtle differences in individual interactions between RT and its inhibitors can be detected by comparison of all structures in this study.
引用
收藏
页码：1047 / 1059
页数：13
相关论文
共 50 条
  • [1] Systematic Investigation of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase (NNRTIs)
    Anton Beyer
    Luckhana Lawtrakul
    Supa Hannongbua
    Peter Wolschann
    Monatshefte für Chemie / Chemical Monthly, 2004, 135 : 1047 - 1059
  • [2] Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
    Wang, Yali
    De Clercq, Erik
    Li, Guangdi
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (10) : 813 - 829
  • [3] The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
    De Clercq, E
    ANTIVIRAL RESEARCH, 1998, 38 (03) : 153 - 179
  • [4] Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
    De Clercq, E
    FARMACO, 1999, 54 (1-2): : 26 - 45
  • [5] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [6] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [7] The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
    Namasivayam, Vigneshwaran
    Vanangamudi, Murugesan
    Kramer, Victor G.
    Kurup, Sonali
    Zhan, Peng
    Liu, Xinyong
    Kongsted, Jacob
    Byrareddy, Siddappa N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4851 - 4883
  • [8] QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Duchowicz, Pablo R.
    Fernandez, Michael
    Caballero, Julio
    Castro, Eduardo A.
    Fernandez, Francisco M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 5876 - 5889
  • [9] Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
    Moreno, S
    Casado, JL
    Pérez-Elias, MI
    Dronda, F
    Antela, A
    Moreno, A
    Gutiérrez, C
    AIDS, 2003, 17 (09) : 1413 - 1414
  • [10] Mechanisms of resistance of HIV-1 reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Boyer, PL
    Tantillo, C
    Ding, J
    Ferris, AL
    Clark, P
    Arnold, E
    Hughes, SH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 6 - 6
12345